Mark Terrence Finn
Independent ChairmanMr. Mark Terrence Finn is Chairman, Chief Executive Officer and Chief Compliance Officer of Vantage Consulting Group, Inc. He is Independent Chairman of Cibus, Inc. from August 06, 2025. He was Lead Independent Director of Cibus, Inc. from October 12, 2023. He is Independent Director of Cibus, Inc. from June 01, 2023. He is Member of Advisory Board of Celtic Pharma Management L.P. He is Member of Advisory Board of Auven Therapeutics Management L.L.L.P. He is Board Member of Enterin, Inc. from 2020. He is General Partner of Scientia Ventures. He was Founding Member and General Partner of Scientia Ventures. He has investment experience and has devoted his entire professional career to providing investment services to the business community. In the mid-seventies he joined the predecessor to Vantage Consulting Group as a consultant and was asked to serve as its Chairman and Chief Executive Officer in 1986, a capacity in which he continues to serve today. He shares responsibility with the Chief Investment Officer for the development of investment strategy and leads firm’s discovery and due diligence on new investment managers and strategies. He began his career at Virginia National Bank in 1968 where he rose to Trust Executive Officer and Chief Investment Officer. From 1984 through 1994, he also served on the Board of Trustees of the Virginia Retirement System. He served as the Vice Chairman and Chief Operating Officer for Lindner Asset Management from 1999 through 2001. He served as an Independent Director on the Legg Mason Partners Fund Board from 1990 through 2019. He serves as the Lead Director and Chairman of Finance and Audit on the board of Cibus Global, a biotechnology firm focused on non-transgenic agricultural crop breeding as well as the Enterin, Inc, Auven Therepeutics and Chartline boards. He taught investments at the University of Virginia’s Darden School of Business and served for few decades on the adjunct faculty at the Mason School of Business at the College of William & Mary, where he also received his MBA. He serves on the board of managers of the Managing Member of New Ventures I, LLC a venture capital fund investing in biotechnology related entities and New Ventures Select, LLC, a pharmaceutical royalty fund, as well as the New Ventures III, Vantage Multi-Strategy Fund, LP, New Ventures as Solutions, LLC and New Ventures as Solutions II, LLC Managing Member boards.
公司職務
- 公司名稱Cibus, Inc.股票代碼CBUS職務Independent Chairman共事同僚
- CWCraig WichnerChief Executive Officer
- PRPeter R. BeethamCo-Founder, President & COO
- GFGregory F. GocalCo-Founder, Chief Scientific Officer & Executive VP
- RBRory Balfour RiggsCo-Founder & Director
- JSJason StokesChief Administrative Officer, General Counsel & Corporate Secretary
- GPGerhard PranteIndependent Director
- AJAugust J. MorettiIndependent Director
- JLJean-Pierre LehmannIndependent Director
